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EDITORIAL
Advancing and prioritizing research on oral clefts in Brazil☆,☆☆
Avançando e priorizando a pesquisa sobre fissuras orais no Brasil
George L. Wehby
MPH, PhD, Associate Professor, Department of Health Management and Policy, College of Public Health,  
University of Iowa, Iowa, USA
Research on oral clefts has noticeably grown over the past 
two decades to cover its various aspects, including etiology, 
epidemiology, prevention, treatments, health services, 
and health and socioeconomic outcomes of patients and 
families. Researchers from multiple disciplines have joined 
efforts to investigate these complex areas. Brazil provides 
a unique setting for these studies for several reasons. As 
the largest country in South America, Brazil has a large 
number of newborns with oral clefts each year, crudely 
estimated between 2,900 and 4,400 births in 2011.* Brazil 
also has one of the most diverse populations worldwide, 
making it particularly suited for genetic studies based 
on admixture mapping. Furthermore, Brazil has some of 
the largest centers specialized in treating oral clefts and 
craniofacial anomalies such as the Hospital de Reabilitação 
de Anomalias Craniofaciais (HRAC) or ‘Centrinho” in Bauru, 
São Paulo and the Centro de Atendimento Integrado ao 
Fissurado Lábio-palatal (CAIF) in Curitiba, Paraná, among 
others. Such centers provide a particularly appropriate 
setting for interventional studies related to prevention or 
treatment. 
Research gaps and priorities for oral clefts have been 
identified in a Centers for Disease Control and Prevention 
(CDC) workshop.1 These are useful for researchers in 
Brazil to consider and pursue. However, we identify here 
priorities that are particularly relevant to strengthening 
and expanding research on oral clefts in Brazil under 
four areas: epidemiological surveillance, research on 
environmental and genetic factors, outcome studies, and 
prevention.
Epidemiological surveillance
Population-based surveillance of birth defects is essential for 
building the capacity of epidemiological research. Building 
a nationwide program is the most inclusive approach for 
identifying and tracking birth defects. However, such 
programs may be challenging to design and implement, 
particularly in large countries. In the absence of national 
programs, state-based programs provide a good substitute. 
Souza and Raskin2 describe the currently available 
surveillance programs in Brazil. The program based on live 
birth certificates (declarations) is nationwide. However, 
*This is based on the author’s calculations with the following 
assumptions: crude birth rate of 15 per 1,000 population and a 
total population of 196,655,014 in 2011 (Word Bank: http://data.
worldbank.org/indicator), and a range of clefting incidence from 
1.5/1,000 (Lopez-Camelo et al., 2010) to 1/1,010 (Souza and 
Raskin, 2012).
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as highlighted by the authors, it has several limitations, 
including concerns about completeness and accuracy of 
description. Therefore, there is still a need for building 
population-based programs in Brazil. This is important 
for accurate estimation of the prevalence of oral clefts 
by type, and of the changes in trends over time. Clinic-
based tracking, such as presented by Souza and Raskin,2 
is an alternative when population-based programs are not 
available. However, clinic-based approaches suffer from 
several well-known limitations, including case selection 
bias, which may significantly distort estimates, among 
others. 
Research on environmental and genetic 
factors
In addition to accurate epidemiological tracking, 
collecting rich data on environmental risk factors, 
collectively defined here to include maternal health 
(chronic conditions such as diabetes and obesity, and 
acute problems such as infections and medication use) 
and behavior (such as smoking, alcohol use, nutrition, 
and vitamin use), demographics, socioeconomics, and the 
physical environment (such as air quality and exposures 
to teratogens) for population-based samples is essential 
for research aimed at studying the contributions of these 
factors to the etiology of oral clefts. Similarly, collecting 
DNA from the same samples is essential for studies of 
genetic etiology including gene-environment interaction 
effects, which have been shown to contribute to oral 
clefts, such as between smoking and certain detoxification 
pathway genes.3 Conducting this research specifically in 
the Brazilian population is important given the potential 
heterogeneity in the effects of environmental and genetic 
risk factors between populations, which would limit the 
generalizability of results on certain risk factors based on 
other populations. 
It is also important to conduct research that can capture 
the causal effects of environmental risk factors, not just 
association, such as by applying genetic instrumental 
variables (or Mendelian randomization),4-8 which provides 
another incentive for collecting the environmental and 
genetic data on the same population-based samples. 
This research requires collecting similar data on (ideally 
randomly selected) controls that are representative of 
the unaffected population. Given the likely challenges 
of systematically collecting environmental and genetic 
data on most of the population affected with oral clefts 
in a large country such as Brazil, an alternative would 
be a coordinated data collection across multiple state-
based samples, as performed in the National Birth Defects 
Prevention Study in the United States.& While these studies 
can be conducted using clinic-based samples, the issues of 
limited generalizability and biased estimates due to sample 
selectivity may significantly reduce the value of research 
on environmental risk factors. 
Outcome studies
Another important research area is to understand the 
effects of oral clefts on the health and well-being of 
affected individuals and their families, both during 
childhood and adolescence and as adults. Such research is 
essential for identifying the needs of affected individuals 
and their families, as well as devising interventions to 
address these needs and improve the outcomes of affected 
families. Particular outcomes to consider are infant survival 
and health problems; effectiveness, quality, and cost of 
surgical, medical, dental, and behavioral treatments from 
infancy through early adulthood; access to these treatments; 
child and adolescent psychosocial status; child/adolescent 
academic achievement and long-term health (chronic 
health conditions, healthcare utilization, mortality risks); 
psychosocial wellbeing (mental health, social adaptation, 
marriage); economic performance (educational attainment, 
employment, income); and quality of life. It is also important 
to study the effect of having a child with oral clefts on the 
family’s financial status, quality of life, and parental and 
sibling psychosocial wellbeing. 
Several previous studies have evaluated some of these 
outcomes using data from developed countries;9-15 more 
research is still needed for several of these outcomes, 
especially using robust designs and large population-
based samples from less developed countries, as it is 
unclear to what extent these outcomes are generalizable. 
The outcomes of affected individuals and their families 
may vary with several factors including individual- and 
household-level effects (e.g. parental socioeconomic 
status), neighborhood-level characteristics (e.g. quality 
of schools, availability and quality of health professionals 
with experience in treating patients with oral clefts, and 
social networks and support), and country-level factors 
(e.g. characteristics of the healthcare system and policies 
related to healthcare coverage, and access to and quality 
of healthcare services). Since these factors vary widely 
between countries, population-specific studies may be 
needed to comprehensively assess the needs of affected 
individuals and families in Brazil and to develop policies 
and interventions to address these needs. Without these, it 
is unclear how the results from studies in other populations, 
such as those related to child behavioral health,9,11 long-
term mortality,10 and hospitalization use12 of affected 
individuals apply to Brazil. 
As in the case of studies of etiologic risk factors, 
outcome studies also require coordinated large-scale 
data collection efforts that are population-based, can 
accurately measure several outcomes, and are designed 
to capture long-term outcomes. Some countries with 
universal health insurance systems such as Denmark have 
administrative population-based registries for healthcare 
services use, income/employment, educational 
attainment, and several other social and economic 
indicators that can be linked and used for research 
studies, providing a great resource for health services 
research and socioeconomic outcome studies, particularly 
for studying long-term outcomes.12 Such resources are 
currently unavailable for Brazil, and it is unclear whether 
they can be developed in the near future. In the absence 
&The National Birth Defects Prevention Study: http://www.nbdps.
org/
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of these, an alternative is conducting surveys of affected 
individuals (including adults), their unaffected family 
members, and representative controls of the unaffected 
population. Of course, such studies would ideally include 
a representative sample of the affected population and 
their families, which would depend on the availability of 
nationally representative population-based registries of 
affected individuals. 
In addition to identifying the effects of oral clefts 
on health and well-being, research is also needed to 
identify treatments and interventions that reduce 
cleft co-morbidities and health risks and improve the 
outcomes of affected individuals. These studies can have 
an interventional or observational design. One example 
is an interventional multi-site study that evaluated the 
effects of early systematic pediatric care on neonatal 
mortality and hospitalizations in a sample of infants born 
with oral clefts in several South American countries, in 
collaboration with the Latin American Collaborative Study 
of Congenital Anomalies (ECLAMC).16,17 Another example 
is an observational study that analyzed data routinely 
collected by ECLAMC in their surveillance program for 
congenital anomalies to evaluate how the effects of 
prenatal care on birth weight vary between infants with 
and without oral clefts, since affected individuals are born 
at lower birth weights than unaffected ones.18,19 Additional 
studies are particularly needed to evaluate the effects 
of household and neighborhood characteristics on the 
health, psychosocial wellbeing, education, and economic 
achievement of affected individuals. 
Prevention
Identifying preventive interventions for common birth 
defects is a long-established goal worldwide. The most 
successful example is preventing neural tube defects 
(NTDs) by folic acid supplementation and fortification 
programs. Folic acid has also been suggested to reduce 
both oral cleft occurrence and recurrence (i.e. having a 
second affected child or a first affected child for affected 
mothers), but the evidence is still mixed,20 as it is based on 
observational studies or interventional studies that were 
not randomized and blinded. Souza and Raskin2 report a 
reduction in their clinic-based prevalence of oral clefts 
after the folic acid fortification program was implemented 
in Brazil. However, since that study was clinic-based, it may 
not accurately estimate the prevalence of oral clefts in 
the population. Therefore, their analysis should be viewed 
as descriptive, and their results should be considered with 
caution. Other vitamins/nutrients besides folate, such as 
vitamin B6,21 have also been suggested to play a role, 
although the evidence is still controversial. Therefore, 
randomized double-blinded clinical trials (RCTs) that 
can test vitamin/supplement effects in a large enough 
sample of at risk-women are particularly needed to detect 
moderate risk changes. Since primary occurrence of oral 
clefts is relatively rare, conducting RCTs for occurrence 
may be challenging and cost-prohibitive, as it requires a 
very large sample.20 RCTs are more particularly suited for 
recurrence, which may be at least 30 times as common 
as primary occurrence.22 Brazil is particularly suited 
for these clinical trials since it has several large clinics 
specialized in cleft/craniofacial care that can serve as 
sites for recruitment and intervention. 
An example of one RCT is the Oral Cleft Prevention 
Program (OCPP), which was developed to test the effect of 
a high dose of folic acid (4 mg) taken daily preconception 
and during the first three months of pregnancy on 
recurrence of oral clefts relative to a low dose (0.4 mg).23-25 
The OCPP recruited women at-risk of cleft recurrence in 
several sites in Brazil, but recruitment was suspended in 
2009 due to lower than expected rates of recruitment, 
retention, and pregnancy. However, the OCPP established 
a unique collaborative research infrastructure among some 
of the largest cleft/craniofacial clinics in Brazil that can be 
considered for future interventional studies and provided 
important preliminary data on effectiveness and safety of 
high dose folic acid.24,25
Conclusion
Nationwide efforts are needed in Brazil for building the 
capacity for research on major common birth defects, 
including oral clefts. Brazil is particularly suited for leading 
research in several areas, including environmental and 
genetic factors and prevention. Furthermore, since it is 
unclear whether the findings on health and well-being of 
affected individuals from specific settings apply to other 
countries – especially when generalizing results from 
developed countries to less developed ones – understanding 
the health and socioeconomic well-being of affected 
individuals and their families in Brazil both in the short 
and long term is important in order to identify needs 
and develop interventions for reducing oral cleft-related 
disparities, and maximizing the well-being of affected 
individuals and their families. 
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